In the face of an increasingly complex global pandemic and constantly evolving healthcare cost structures, one thing has become abundantly clear for orthopedic surgeons in the United States: total ...

The PREVENA RESTOR™ Therapy portfolio optimizes post-operative care by delivering negative pressure therapy to the incision and surrounding soft tissue to enhance recovery ST. PAUL, Minn.--(BUSINESS ...

Research presented at the 30th American Association of Hip and Knee Surgeons Annual Meeting (AAHKS) builds on existing evidence that PREVENA™ Therapy lowers surgical site complications and readmission ...

SAN ANTONIO--(BUSINESS WIRE)--KCI, an Acelity Company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s De Novo request for the PREVENA™ Incision Management ...

SAN ANTONIO--(BUSINESS WIRE)--Acelity, a global advanced wound care company, today announced that the PREVENA DUO™ Incision Management System is now available to physicians in the United States. The ...

In December 2025, Solventum announced updated consensus recommendations from an international panel on the clinical use of closed incision negative pressure therapy (ciNPT) with its proprietary ...

MISSISSAUGA, ON, June 22 /CNW/ - Kinetic Concepts, Inc. (KCI), today announced the introduction of the new Prevena(TM) Incision Management System in Canada. Recently licensed by Health Canada to help ...

"The Prevena ™ Peel & Place ™ Dressing with a connector makes active incision management available to more patients by using the V.A.C. ® Therapy Units many hospitals already have in place,” said Joe ...

Prevena is a CE-marked class IIa medical device. The company recalled the device from sale in the US because there was a problem with the tubing connectors not fitting correctly in 2015. The device ...

KCI, an Acelity Company, announced today that recently published data stemming from two studies demonstrate that closed incision negative pressure therapy (ciNPT) with the PREVENA™ Incision Management ...